12 Followers on Owler

Atea

is a Massachusetts-based biopharmaceutical company that discovers and develops direct-acting antiviral, and oral therapies for the treatment of COVID-19 disease... Read more

Overview Competitors Funding News & Insights

Atea

is a Massachusetts-based biopharmaceutical company that discovers and develops direct-acting antiviral, and oral therapies for the treatment of COVID-19 disease... Read more

Chairman & CEO

Jean-Pierre Sommadossi

CEO Approval Rating

90/100

2012

BostonMassachusetts

PublicNASDAQAVIR

Pharmaceuticals & Biotechnology

https://ateapharma.com/

Annual Revenue

$351.4M

Employees

70

News

Atea Pharmaceuticals cuts workforce by ~25% in Q1

Conference Presentation

Atea Pharmaceuticals Announces Presentation of Bemnifosbuvir Preclinical Data at the 38th International Conference on Antiviral Research (ICAR) 2025

Atea Competitors

1

2

3

4

5

6

7

8

9

10

Unlock 12 + competitors

Trending Companies